Merrimack Pharmaceuticals Inc MACK Income Statements

S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Merrimack Pharmaceuticals Inc (MACK)
Merrimack Pharmaceuticals Inc (MACK) Financials

Merrimack Pharmaceuticals Inc (MACK)

15.1575

0.00

(0.00%)

Closed November 27 3:00PM

Delayed by 15 minutes

0.00

0.00

(0.00%)

After Hours: -

Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Annual Quarterly

Quarter End	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Total Revenue	0	0	0	139k	0	0	0	0
Operating Income	-486k	-504k	-607k	-447k	-569k	-531k	-490k	-669k
Pre Tax Income	-478k	-442k	-489k	-271k	-391k	-279k	-228k	-436k
Net Income	-478k	-442k	-492k	-271k	-391k	-279k	-240k	201.37M
Preferred Dividends	0	0	0	0	0	0	0	0
Basic Earnings Per Share (EPS)	0	0	0	0	0	0	0	0
EBIT	-486k	-504k	-607k	-447k	-430k	-531k	-490k	-669k
EBITDA	-486k	-504k	-607k	-447k	-569k	-531k	-490k	-669k

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Total Revenue	144.27M	0	0	0	0	0	0	0
Operating Income	-110.14M	-95.77M	-65.58M	-27.27M	-5.01M	-2.62M	-2.17M	-2.18M
Pre Tax Income	-153.52M	-118.4M	-68.46M	-22.74M	-3.01M	-2.45M	-1.54M	-1.17M
Net Income	-151.74M	472.03M	-40.51M	-17.33M	-3.03M	-2.46M	-1.54M	-1.18M
Preferred Dividends	0	0	0	0	0	0	0	0
Basic Earnings Per Share (EPS)	-1.165	35.376	-3.036	-1.295	-0.226	-0.183	-0.109	-0.082
EBIT	-110.15M	-84.65M	-65.58M	-21.99M	-3.06M	-2.47M	-1.73M	-2.04M
EBITDA	-99.44M	-90.55M	-61.5M	-25.04M	-5.01M	-2.62M	-2.17M	-2.18M

Merrimack Pharmaceuticals

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions